Medical/Pharmaceuticals
Cambrex to Invest $30 Million to Expand Manufacturing Center of Excellence at High Point, NC Facility
EAST RUTHERFORD, N.J., Oct. 7, 2021 /PRNewswire/ -- Cambrex today announced that it is expanding its manufacturing center of excellence inHigh Point, NC. The $30+ million investment is designed to meet the continually growing demand for small molecule development and manufacturing services. The ...
CDD Gives Back with Open Access Data Visualization Tool
SAN FRANCISCO, Oct. 7, 2021 /PRNewswire/ -- Collaborative Drug Discovery, Inc. (CDD) announced today that it is providing a full featured, standalone software tool to the scientific community for free.CDD Visualization is an intuitive browser-based application that allows scientists to visualize ...
Solving the Mystery of Sleep by "Lighting Up the Brain" presented at WCN 2021 by Neuroscientist Gero Miesenböck
LONDON, Oct. 7, 2021 /PRNewswire/ -- Solving the mystery of sleep by studying brain mechanisms that regulate sleep and waking was research presented by Gero Miesenböck, Waynflete Professor of Physiology at the Centre for Neural Circuits and Behavior,Oxford, England at the virtual 25th Biennial Wo...
Deep Longevity Launches Longevity Medicine Course for Physicians with Industry Experts
HONG KONG, Oct. 7, 2021 /PRNewswire/ -- Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK)'s Deep Longevity, Inc, a company acquired on14 December 2020 which develops artificial intelligence to track human aging and ...
Ascensia Diabetes Care Launches the "This is Diabetes" Competition to Highlight the Need for Access to Diabetes Care in Support of IDF's World Diabetes Day
BASEL, Switzerland, Oct. 7, 2021 /PRNewswire/ -- Today Ascensia Diabetes Care, makers of the CONTOUR® Blood Glucose Monitoring system portfolio and distributors of the Eversense® Continuous Glucose Monitoring system, has launched its "This is Diabetes" art and photography competition as the comp...
Research on Using Fluid Biomarkers to Advance Drug Treatments and Therapies for Alzheimer's, Traumatic Brain Injury, Concussion, and Other Neurodegenerative Diseases Presented at World Congress of Neurology 2021 by Neuroscientist Henrik Zetterberg
LONDON, Oct. 7, 2021 /PRNewswire/ -- New developments in the field of blood biomarkers for brain diseases including traumatic brain injury (TBI), and neurodegenerative diseases such as Alzheimer's, were unveiled during three lectures at the 25th BiennialWorld Congress of Neurology, October 3–7, 2...
Debiopharm and Dexa Medica Launch Triptorelin Collaboration to Bring New Hope to Women With Endometriosis
LAUSANNE, Switzerland and TANGERANG, Indonesia, Oct. 7, 2021 /PRNewswire/ --
Debiopharm (www.debiopharm.com
Luciole Pharmaceuticals and Cyclica Announce Research Collaboration to Accelerate Discovery of Novel Medicines
NATICK, Mass. and TORONTO, Oct. 7, 2021 /PRNewswire/ -- Luciole Pharmaceuticals, a startup company focused on the discovery and development of small molecules that enhance the repair of oxidative damage to mitochondrial DNA (mtDNA), and Cyclica, the partner of choice for data-driven drug discovery...
endpoint and Berlinger Collaborate to Provide Complete Visibility of the Historical Temperature Journey of an IMP
Fully integrated solution: Turn a 25-day manual temperature-monitoring data evaluation into instant decision making SAN FRANCISCO and SWITZERLAND, Oct. 6, 2021 /PRNewswire/ -- endpoint Clinical , the leader in global interactive response technology (IRT®) for clinical trials, andBerlinger & Co. A...
ArisGlobal LifeSphere® MultiVigilance is selected by Asahi Kasei Pharma
MIAMI and TOKYO, Oct. 6, 2021 /PRNewswire/ -- Asahi Kasei Pharma Corp. has selectedLifeSphere® MultiVigilance as a new safety database with the purpose of building a system that supports efficiency, regulatory compliance, and global collaboration over the long term. In addition, Asahi Kasei Pharm...
Neopharma Technologies announces wholesale investment round with OnMarket
Targeting full commercilaisation of its patented and world-leading
drugs-of-abuse testing technology.
OnMarket Live Offer for Professional & Sophisticated Investors:
https://www.onmarket.com.au/offers/neopharma-w
146th Annual Meeting of the American Neurological Association to Focus on Research and Development of Neurologic Disease Therapeutics
World's Leading Academic Neurologists and Neuroscientists to Present at ANA2021 MOUNT LAUREL, N.J., Oct. 6, 2021 /PRNewswire/ -- This year's Virtual Annual Meeting,ANA2021 will welcome more than 1,000 academic neurologists and neuroscientists from around the world to share exciting research updat...
Week's Top Stories
Most Reposted
DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 276 media titles]
2026-10-06 05:28Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 271 media titles]
2026-10-01 10:00ViewSonic Launches VG1457 Dual-Screen Portable Monitor for Productivity Anywhere
[Picked up by 269 media titles]
2026-09-30 10:50Sunway University to Host Asia's First Global Tipping Points Conference 2026
[Picked up by 263 media titles]
2026-09-30 12:11Vestas Powers Up Vietnam's Clean Energy Ambitions with Two New Projects Under PDP8 Totaling 16 Wind Turbines
[Picked up by 263 media titles]
2026-10-02 16:27